On Monday morning, Genmab announced a set of phase 1/2 clinical trial results for its rinatabart sesutecan (Rina-S) drug, which it's developing for a type of uterine cancer. The company said the drug ...

Investors were surely discovering drug discovery company AbCellera Biologics ( ABCL 6.19%) as the trading week kicked off on ...

In the note, Morgan Stanley said that it believes Broadcom will post solid results when it reports its second quarter of ...

The Trade Desk stock gained 19% on May 9 on the news and then added another 12% on May 12 on news that the U.S. and China were lowering their tariff rates for 90 days. Due to its exposure to ...

Well before market open, The Wall Street Journal published an article asserting that Meta plans to offer its advertisers the ...

The unquestioned leader in the GPU space is Nvidia, which commands an over 80% market share. Not only is Nvidia larger than AMD, but it's also been growing its data center revenue more quickly. Last ...

Recent trading activity from some of Wall Street's most-followed investors shows a clear pattern between some of the hottest ...

Shares of Meta Platforms ( META 3.61%) were moving higher last month after the social media giant jumped on a ...

With today's gain, gold has now appreciated 30.7% this year. However, most gold mining stocks are up even more, as you can see. This is because their profit growth will be higher than the rise in gold ...

Shares of Tempus AI ( TEM 14.71%) soared on Monday. The company's stock jumped 15% as of market close. The spike comes as the ...

With Monday's fall, SAIC is trading at just 10 times future earnings. That's nearing a recent historical low. It's possible we haven't bottomed out yet, but for long-term-focused investors, SAIC has ...

Shares of IonQ ( IONQ 0.74%), a developer of quantum computers and related platforms, were soaring last month, primarily in response to favorable coverage in Barron's, and an article that said it was ...